Top 10 Cheapest Stocks To Buy For 2014

Here at The Motley Fool, I’ve long cautioned investors to keep a close eye on inventory levels. It’s a part of my standard diligence when searching for the market’s best stocks. I think a quarterly checkup can help you spot potential problems. For many companies, products that sit on the shelves too long can become big trouble. Stale inventory may be sold for lower prices, hurting profitability. In extreme cases, it may be written off completely and sent to the shredder.

Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven’t materialized. Is the current inventory situation at EnerSys (NYSE: ENS  ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is EnerSys doing by this quick checkup? At first glance, OK, it seems. Trailing-12-month revenue decreased 0.3%, and inventory decreased 2.2%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue dropped 3.5%, and inventory shrank 2.2%. Over the sequential quarterly period, the trend looks healthy. Revenue grew 2.7%, and inventory dropped 6.9%.

Top 10 Cheapest Stocks To Buy For 2014: Sucampo Pharmaceuticals Inc ( SCMP)

Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company’s prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company’s products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl).

AMITIZA

The Company’s AMITIZA is being marketed in the United States for three gastrointestinal indications under a license agreement, or the Takeda Agreement, with Takeda Pharmaceutical Company Limited, or Takeda. The three gastrointestinal indications include chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. AMITIZA for OIC received approval from the United States Food and Drug Administration (FDA), in April 2013. In Japan, AMITIZA is marketed under a license, commercialization and supply agreement, or the Abbott Agreement, with Abbott Japan Co. Ltd. (Abbott), for the gastrointestinal indication of chronic constipation (CC), excluding constipation caused by organic diseases. In Switzerland, the Company is marketing AMITIZA.

RESCULA

The Company holds license agreements for RESCULA in the United States and Canada and the rest of the world, with the exception of Japan, Korea, Taiwan and the People’s Republic of China. The Company is commercializing RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% for the lowering of intraocular pressure (IOP), in patients with open-angle glaucoma or ocular hypertension in th e United States. RESCULA may be used as an agent or concomit! antly with other topical ophthalmic drug products to lower intraocular pressure. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.

Advisors’ Opinion:

  • [By James Brumley]

    Still, for the nimble who know when to get out, OREX is one of the few cheap stocks worth a closer look.

    Sucampo Pharmaceuticals (SCMP)

    Finally, though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve seen SCMP stock suffer since peaking in mid-January. It’s not a pullback that’s bound to go unchallenged by the bulls.

  • [By Roberto Pedone]

    Another under-$10 stock that’s starting to trend within range of triggering a major breakout trade is Sucampo Pharmaceuticals (SCMP), which is engaged in the discovery, development and commercialization of proprietary drugs based on prostones, and other novel drug technologies. This stock is off to a decent start in 2013, with shares up by 26%.

    If you take a look at the chart for Sucampo Pharmaceuticals, you’ll notice that this stock has been downtrending badly for the last four months, with shares dumping hard from its high of $10.48 to its recent low of $5.40 a share. During that downtrend, shares of SCMP have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the downside volatility for SCMP looks to be over in the short-term since the stock has started to reverse its downtrend and enter an uptrend. That reverse is quickly pushing shares of SCMP within range of triggering a major breakout trade above a key downtrend line.

    Traders should now look for long-biased trades in SCMP if it manages to break out above some near-term overhead resistance levels at $6.33 to $6.66 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 115,383 shares. If that breakout triggers soon, then SCMP will set up to re-test or possibly take out its next major overhead resistance levels at $7.09 to $7.67 a share. Any high-volume move above those levels will then give SCMP a chance to tag $8 to $9 a share.

    Traders can look to buy SCMP off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $5.58 to $5.40 a share. One can also buy SCMP off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Cheapest Stocks To Buy For 2014: StanCorp Financial Group Inc.(SFG)

StanCorp Financial Group, Inc., through its subsidiaries, provides insurance products and asset management solutions in the United States. The company operates in two segments, Insurance Services and Asset Management. The Insurance Services segment offers group and individual disability, group life, group accidental death and dismemberment, group dental, and group vision insurance products, as well as absence management services to individuals and employers. This segment sells its group insurance products through sales representatives, as well as through independent employee benefit brokers and consultants; and individual disability insurance products through brokers and master general agents primarily to physicians, lawyers, executives, other professionals, and small business owners. As of December 31, 2010, it had approximately 31,000 group insurance policies in force covering approximately 6.8 million employees. The Asset Management segment provides 401(k) plans, 403(b) plans, 457 plans, defined benefit plans, money purchase pension plans, profit sharing plans, and non-qualified deferred compensation products and services through an affiliated broker-dealer. This segment also offers investment advisory and management, commercial mortgage loan origination and servicing, and financial planning services, as well as individual fixed-rate annuity, group annuity, and retirement plan trust products. In addition, the company owns and manages real estate properties for sale; and operates an online financial life planning and management service. StanCorp Financial Group, Inc. was founded in 1998 and is headquartered in Portland, Oregon.

Advisors’ Opinion:

  • [By David Merkel]

    The two stocks in question are Stancorp Financial (SFG) and National Western Life Insurance (NWLI). The short cases for both are based on a naive view of how insurance companies work.

Top 10 Cheapest Stocks To Buy For 2014: JMP Group Inc (JMP)

JMP Group Inc., through its subsidiaries, operates as an investment banking, asset management, and corporate credit management company in the United States. The company provides various investment banking products and services, such as capital raising, mergers and acquisitions transaction, and other strategic advisory services to corporate clients. It also offers sales and trading services, which include distributing equity research products, communicating proprietary investment recommendations, executing equity trades on behalf of institutional clients, and marketing the securities of companies, as well as related brokerage services to institutional investors. In addition, the company provides proprietary equity research in five industries, including consumer, financial services, healthcare, real estate, and technology industries. Further, it provides asset management products and services to institutional investors, and high net-worth individuals; and involves in the man agement of collateralized loan obligations. JMP Group Inc. was founded in 1999 and is headquartered in San Francisco, California with additional offices in New York, New York; Boston, Massachusetts; Chicago, Illinois; and Alpharetta, Georgia.

Advisors’ Opinion:

  • [By Marc Bastow]

    Full-service investment banking, asset management and corporate credit management firm JMP Group (JMP) raised its quarterly dividend 13% to 4.5 cents per share, payable April 11 to shareholders of record as of March 28.
    JMP Dividend Yield: 2.41%

Top 10 Cheapest Stocks To Buy For 2014: ING Groep NV (ISP)

ING Groep N.V. (ING) is a global financial institution offering banking, investments, life insurance and retirement services to meet the needs of the customers. The Company’s segments include banking and insurance. Banking segment includes retail Netherlands, retail Belgium, ING direct, retail central Europe (CE), retail Asia, commercial banking (excluding real estate), ING real estate and corporate line banking. Insurance segment includes insurance Benelux, insurance central and rest of Europe (CRE), insurance United States (US), Insurance US closed block VA, insurance Asia/Pacific, ING investment management (IM) and corporate line insurance. In November 2013, the Company completed the sale of ING Hipotecaria to Banco Santander (Mexico), S.A. In December 2013, the Company completed the sale of its 33.3% interest in China Merchants Fund to its joint venture partners China Merchants Bank Co Ltd and China Merchants Securities Co Ltd, and divested ING Life Korea to MBK Partner s. Advisors’ Opinion:

  • [By Tom Stoukas]

    UniCredit SpA and Intesa Sanpaolo SpA (ISP), Italy’s biggest banks, dropped more than 1 percent as the nation’s benchmark FTSE MIB Index slid 1.2 percent. Rio Tinto Group led mining companies lower after a measure of Chinese manufacturing missed a preliminary estimate. Aryzta AG rallied the most in six months as the Swiss supplier of bakery products reported results that topped projections.

Top 10 Cheapest Stocks To Buy For 2014: Korea Electric Power Corp (KEP)

Korea Electric Power Corporation (KEPCO), incorporated on January 1, 1982, is engaged in the generation, transmission and distribution of electricity and development of electric power resources in the Republic of Korea. KEPCO’s business operations include nuclear, hydro and thermal generation; transmission and distribution, and resources development. KEPCO consists of power generation companies, subsidiaries and affiliates, and other share-holding companies. On January 5, 2010, KEPCO developed the prototype of next-generation electric vehicle chargers.

KEPCO completed consulting projects in Myanmar, the Philippines, Indonesia, Libya, Ukraine and Paraguay, and is working on 12 projects in Western Africa, Cambodia, Bangladesh, Pakistan, Egypt, Saudi Arabia and Azerbaijan. KEPCO is investing in green growth business, which includes implementation of Smart Grid and electric vehicle charging infrastructure and reduction of greenhouse gas emissions. KEPCO is engag ed in development of renewable energy projects, including photovoltaic, wind and tidal energy to realize low carbon green growth. KEPCO’ s overseas renewable energy projects include wind farms in Gansu (99 megawatts) and Inner Mongolia (1,075 megawatts) in China. KEPCO has secured an annual 520,000 tons worth of carbon emission rights. KEPCO has nine CDM projects related to wind generation project in China, out of 18 CDM projects.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Among the sector stocks, Pure Cycle (NASDAQ: PCYO) was down more than 1.3 percent, while Korea Electric Power (NYSE: KEP) tumbled around one percent.

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    Utilities stocks gained Friday, with Korea Electric Power (NYSE: KEP) leading advancers. Meanwhile, gainers in the sector included Huaneng Power International (NYSE: HNP), with shares up 2.1 percent, and Pampa Energia SA (NYSE: PAM), with shares up 2.5 percent.

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    Utilities stocks gained Friday, with Korea Electric Power (NYSE: KEP) leading advancers. Meanwhile, gainers in the sector included Huaneng Power International (NYSE: HNP), with shares up 1.8 percent, and Hawaiian Electric Industries (NYSE: HE), with shares up 1.4 percent.

Top 10 Cheapest Stocks To Buy For 2014: Rigel Pharmaceuticals Inc.(RIGL)

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.

Advisors’ Opinion:

  • [By Sean Williams]

    What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL  ) , a clinical-stage small molecule drug company focused on inflammatory and autoimmune disorders, dropped as much as 21% after the company resumed full responsibility for its rheumatoid arthritis pill, Fostamatinib, and reported topline data from two late-stage studies involving the drug.

  • [By Max Macaluso, Ph.D.]

    Early Tuesday morning, Rigel Pharmaceuticals  (NASDAQ: RIGL  ) and its now-ex-partner, AstraZeneca (NYSE: AZN  ) , reported late-stage clinical trial results for the experimental rheumatoid arthritis drug Fostamatinib. In the following video, health-care analyst Max Macaluso discusses why Rigel dropped 18% after the news was released and the risks that lie ahead for Rigel Pharmaceuticals.

  • [By Keith Speights]

    Pain-medication pain
    Rigel Pharmaceuticals (NASDAQ: RIGL  ) experienced pain this week, resulting from its drug intended to help rheumatoid arthritis patients suffer less pain. Shares fell almost 23%.

  • [By Sean Williams]

    It wasn’t nearly as exciting a week for Rigel Pharmaceuticals (NASDAQ: RIGL  ) , which regained full rights to rheumatoid arthritis pill Fostamatinib from AstraZeneca on Tuesday. The pair actually reported a statistically significant ACR20 response rate at 24 weeks in two trials, but the data isn’t expected to be conclusive enough to gain FDA approval. AstraZeneca, not wanting to spend any more on the program, took a $140 million charge and returned all licensing back to Rigel. With the prospect of high trial costs and a drug which did well, but perhaps not well enough to compete with competition already on the market, Rigel is now in a tough position and is worth avoiding at all costs.

Top 10 Cheapest Stocks To Buy For 2014: Hertz Global Holdings Inc(HTZ)

Hertz Global Holdings, Inc., through its subsidiaries, engages in the car and equipment rental businesses worldwide. It operates in two segments, Car Rental and Equipment Rental. The Car Rental segment engages in the ownership and lease of cars. This segment operates car rental locations at or near airports, as well as in central business districts and suburban areas of cities in the United States, Canada, France, Germany, Italy, the United Kingdom, Spain, the Netherlands, Switzerland, Belgium, Luxembourg, the Czech Republic, the Slovak Republic, Australia, New Zealand, China, and Brazil. It also operates retail used car sales locations in the United States and France. The Equipment Rental segment rents earthmoving equipment, material handling equipment, aerial and electrical equipment, air compressors, generators, pumps, small tools, compaction equipment, and construction-related trucks. In addition, this segment sells new equipment, and consumables, such as gloves and ha rdhats. The company also offers claim administration services, such as investigating, evaluating, negotiating, and disposing of various claims, including third-party, first-party, bodily injury, property damage, general liability, and product liability. Hertz Global serves various industries, such as construction, petrochemical, automobile manufacturing, railroad, power generation, and shipbuilding. The company was founded in 1918 and is headquartered in Park Ridge, New Jersey.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Timing of the transaction completion is mid 2015, following final approval of the BoD, receipt of favorable opinion on tax free status from IRS, shareholder approval, & all regulatory approvals. As a point of interest we have seen several announcements recently where an announcement of the split drives the stocks up 10% and quickly fades as timing sets in and market risk still exists. recent examples [Hertz (HTZ), FMC Corp (FMC), Agilent (A), Noble (NE), CBS (CBS)]. I would expect the stock to fade hard from these levels

  • [By Monica Gerson]

    Breaking news

    Kratos Defense & Security Solutions (NASDAQ: KTOS) announced today that its Public Safety & Security (PSS) Division recently received an initial $4.5 million contract award for the deployment of specialized security and surveillance related products, equipment, and system integration services across a large public school district located in the eastern United States. To read the full news, click here. Google’s (NASDAQ: GOOG) upcoming unconventional stock split will enable Co-founder Sergey Brin and Larry Page to maintain close control over the company. The stock split will diminish shareholders voices and modify how the company is represented in the S&P 500 index. To read the full news, click here. Veeva Systems (NYSE: VEEV) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed public offering of shares of its Class A common stock. To read the full news, click here. The Hertz (NYSE: HTZ) today announced that its board of directors has approved plans to separate into two independent, publicly traded companies. To read the full news, click here.

    Posted-In: Credit Suisse US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Top 10 Cheapest Stocks To Buy For 2014: Bridgeline Digital Inc.(BLIN)

Bridgeline Digital, Inc. engages in the development of Web experience management (WEM) product and interactive technology solutions that help organizations to optimize business processes. Its iAPPS product suite includes iAPPS Content Manager that allows non-technical users to create, edit, and publish content through a browser-based interface; iAPPS Commerce, an online B2B and B2C eCommerce solution, which allows users to maximize and manage various aspects of commerce initiatives; and iAPPS Marketier, a marketing lifecycle management solution that comprises customer transaction analysis, email management, surveys and polls, event registration, and issue tracking to measure campaign return on investment and client satisfaction. The company also provides iAPPS Analyzer to manage, measure, and optimize Web properties by recording detailed events and mine data within a Web application for statistical analysis; and iAPPS Rapid Site for building custom Websites. It delivers it s iAPPS product suite through cloud-based software as a service business model or via a traditional perpetual licensing business model. The company?s end-to-end interactive technology solutions consist of digital strategy, user-centered design, Web application development, SharePoint development, rich media development, search engine optimization, and Web application hosting management. Bridgeline Digital serves various markets, such as financial services, consumer products and goods, health services and life sciences, high technology (software and hardware), retail brand names, transportation and storage, associations and foundations, and the U.S. Government through its direct sales force. The company was formerly known as Bridgeline Software, Inc. and changed its name to Bridgeline Digital, Inc. in March 2010. Bridgeline Digital, Inc. was founded in 2000 and is based in Burlington, Massachusetts.

Advisors’ Opinion:

  • [By Bryan Murphy]

    Congratulations to anyone who owned shares of Bridgeline Digital Inc. (NASDAQ:BLIN) before today. You’re now up 35% for the day so far, and still counting. The big pop from BLIN stemmed from the announcement that it scored a pretty significant deal with an organization consisting of nearly 4000 dentists and doctors. The terms of the deal are simple enough… Bridgeline Digital will host and service websites for the practitioners in the group for a period of three years, and in return, BLIN will receive $7 million.

Top 10 Cheapest Stocks To Buy For 2014: Document Security Systems Inc (DSS)

Document Security Systems, Inc. (DSS), incorporated on May 30, 1984, develops, markets, secure technologies. The Company specializes in fraud and counterfeit protection for all forms of printed documents and digital information. The Company holds numerous patents for optical deterrent technologies that provide protection of printed information from unauthorized scanning and copying. The Company operates three production facilities, a security and commercial printing facility, a packaging facility and a plastic cards facility, where the Company produces secure and non-secure documents for its customers. The Company licenses its anti-counterfeiting technologies to printers and brand-owners. In addition, the Company has a digital division which provides cloud computing services for its customers, including disaster recovery, back-up and data security services. The Company operates in four segments: DSS Printing Group, DSS Plastics Group, DSS Packaging Group and DSS Digital Gr oup. In June 2013, Document Security Systems Inc announced the closing of its previously announced merger with Lexington Technology Group, Inc. In October 2013, the Company announced that it has acquired two portfolios that will enable DSS to develop protected hardware and peripherals that incorporate core DSS security technologies.

The Company provides document security technology to security printers, corporations, consumer product companies and governments worldwide and for currency, identifications, certifications, travel documents, prescription and medical forms, consumer product and pharmaceutical packaging, and school transcripts. Its products are delivered on paper, plastic, or digitally via its AuthentiGuard DX product suite.

DSS Printing Group

The DSS Printing Group provides secure and commercial printing services for end-user customers along with technical support for the Company’s technology licensees. The division produc es a wide array of printed materials such as security paper,! vital records, prescription paper, birth certificates, receipts, manuals, identification materials, entertainment tickets, secure coupons, parts tracking forms, brochures, direct mailing pieces, catalogs, business cards, etc. The division also provides the basis of research and development for its security printing technologies.

DSS Plastics Group

The DSS Plastics Group manufactures laminated and surface printed cards which can include magnetic stripes, bar codes, holograms, signature panels, invisible ink, micro fine printing, guilloche patterns, biometric, radio frequency identification (RFID) and watermarks for printed plastic documents such as identity cards, event badges, and driver’s licenses.

DSS Packaging Group

The DSS Packaging Group produces custom paperboard packaging serving clients in the pharmaceutical, beverage, photo packaging, toy, specialty foods and direct marketing industries, among others. The divisi on incorporates the Company’s security technologies into printed packaging to help companies prevent or deter brand and product counterfeiting.

DSS Digital Group

The DSS Digital Group provides data center centric solutions to businesses and governments delivered via the cloud. This division is also develops digital data security technologies based on the Company’s optical deterrent technologies.

The Company competes with Standard Register Company, De La Rue Plc, Sharp, Xerox Canon, Ricoh, Hewlett Packard, Eastman Kodak, NoCopi Technologies, Graphic Security Systems Corporation, RR Donnelley, Canadian printer Quebecor World, Bristol ID, AbNote, LaserCard Corporation and L-1 Identity Solutions, Rock-Tenn Company, Caraustar Industries, Inc., Graphic Packaging Holding Company and Mead Westvaco.

Advisors’ Opinion:

  • [By Susan Decker]

    Document Security Systems Inc. (DSS), based in Rochester, New York, is suing Facebook Inc. and LinkedIn Corp. for infringing technology covering online collaboration. The patents were acquired in a reverse merger with Lexington Technology Group Inc., an intellectual property company. The shares have fallen 33 percent since the deal closed on July 1.

  • [By James E. Brumley]

    In a perfect world stocks would move in predictable, manageable ways. We don’t live – nor do we trade in – a perfect world. In the real world we have to adapt to and deal with the curve balls the market throws us, and there are no two stocks that illustrate that point better than Document Security Systems, Inc. (NYSEMKT:DSS) and Nortech Systems Incorporated (NASDAQ:NSYS) to today. While both NSYS and DSS are up today, one’s overbought and ripe for a pullback, while the other is likely at the beginning of a trade-worthy rally.

  • [By Roberto Pedone]

    Document Security Systems (DSS) is engaged in fraud and counterfeit protection for all forms of printed documents and digital information. This stock closed up 8.7% to $1.68 in Tuesday’s trading session.

    Tuesday’s Range: $1.48-$1.68

    52-Week Range: $1.37-$4.60

    Tuesday’s Volume: 755,000

    Three-Month Average Volume: 472,073

    From a technical perspective, DSS ripped higher here right above some near-term support at $1.45 with above-average volume. This stock has been downtrending badly for the last three months, with shares dropping from its high of $3.64 to its recent low of $1.37. During that move, shares of DSS have been making mostly lower highs and lower lows, which is bearish technical price action. That said, shares of DSS have now started to rebound off that $1.37 low and it’s now quickly moving within range of triggering a near-term breakout trade. That trade will hit if DSS manages to take out some near-term overhead resistance levels at $1.75 to $1.88 with high volume.

    Traders should now look for long-biased trades in DSS as long as it’s trending above some near-term support levels at $1.45 to $1.37 and then once it sustains a move or close above those breakout levels with volume that hits near or above 472,073 shares. If that breakout triggers soon, then DSS will set up to re-test or possibly take out its 50-day moving average at $2.05 to its next major resistance area at $2.30. Any high-volume move above those levels will then put its 200-day at $2.39 or $3 into range for shares of DSS.

Top 10 Cheapest Stocks To Buy For 2014: Consolidated Graphics Inc. (CGX)

Consolidated Graphics, Inc., together with its subsidiaries, provides general commercial printing and print-related services in the United States and internationally. The company’s services include traditional print services, such as electronic prepress, digital and offset printing, finishing, and storage and delivery of custom manufactured printed documents; and fulfillment and mailing services for such printed materials. It also offers technology solutions that enable its customers to procure and manage printed materials and/or design, procure, distribute, track, and analyze results of printing-based marketing programs and activities; and multi-media capabilities, which allow customers to supplement the message of their printed materials through other media, such as the Internet, email, or text messaging. The company prints multi-color marketing materials, product and capability brochures, point-of-purchase displays, packaging, direct mail pieces, shareholder communicat ions, trading cards, calendars, and photo books, as well as customized materials for the financial services, insurance, healthcare, and other industries. In addition, it offers e-commerce software solutions and other print-related services. The company’s customers include national and local corporations operating in a range of industries, as well as advertising agencies, graphic design firms, catalog retailers, direct mail marketers, state and local governments and quasi-governmental agencies, educational institutions, not-for-profit associations, and political campaign organizations. Consolidated Graphics, Inc. was founded in 1985 and is headquartered in Houston, Texas.

Advisors’ Opinion:

  • [By Monica Gerson]

    Breaking news

    Starwood Hotels & Resorts Worldwide (NYSE: HOT) reported a gain in its third-quarter core earnings and lifted its full-year earnings forecast. To read the full news, click here. Procera Networks (NASDAQ: PKT) and Skyfire, a fully-owned subsidiary of Opera Software, today announced a joint solution and partnership to tackle the rapid growth of video traffic on global mobile networks, based on an open, scalable ICAP architecture. To read the full news, click here. R. R. Donnelley & Sons Company (NASDAQ: RRD) and Consolidated Graphics (NYSE: CGX) jointly announced today that they have signed a definitive agreement by which RR Donnelley will acquire Consolidated Graphics, a provider of digital and commercial printing, fulfillment services, print management and proprietary Internet-based technology solutions. To read the full news, click here. Dunkin’ Brands Group (NASDAQ: DNKN) reported a 36% rise in its third-quarter income. To read the full news, click here.

    Posted-In: Jobless Claims JP Morgan US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

  • [By Seth Jayson]

    Consolidated Graphics (NYSE: CGX  ) reported earnings on May 15. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q4), Consolidated Graphics met expectations on revenues and crushed expectations on earnings per share.